Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

113
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
113

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronological Changes in Causes of Death in Brain Death Donors: A 7-Year Analysis in the Tuscany Region.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same author

Infectious Risk Donor Status in Uncontrolled Donation After Circulatory Death and Liver Transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Success is not final, failure is not fatal; it is the courage to continue (improving) that counts.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

A Decline in Donors After Brain Death: A Transient Phenomenon?

Transplantation·2026
Same author

Out of hospital cardiac arrest, uncontrolled donation after circulatory death only lung and lung transplants.

Resuscitation·2026
Same author

Cytokines Adsorption During Ex Situ Machine Perfusion of Liver Grafts from Elderly Donors: A Pilot, Prospective, Randomized Study.

Life (Basel, Switzerland)·2026

Related Experiment Video

Updated: Oct 14, 2025

Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy
05:03

Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy

Published on: April 17, 2020

5.7K

Hemodynamic management in brain dead donors.

Chiara Lazzeri1, Manuela Bonizzoli2, Cristiana Guetti2

  • 1Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero Universitaria Careggi, Florence 50134, Italy. lazzeri.ch@gmail.com.

World Journal of Transplantation
|November 1, 2021
PubMed
Summary
This summary is machine-generated.

Effective hemodynamic management in brain death donors (DBD) is crucial for organ retrieval. This review highlights optimal vasoactive and hormonal therapies, and monitoring strategies for marginal donors to improve organ transplantation outcomes.

Keywords:
Brain-dead donorsEchocardiographyHemodynamicHormanal therapyManagementVasoactive drugs

More Related Videos

Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

1.8K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.0K

Related Experiment Videos

Last Updated: Oct 14, 2025

Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy
05:03

Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy

Published on: April 17, 2020

5.7K
Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

1.8K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.0K

Area of Science:

  • Organ transplantation
  • Critical care medicine
  • Nephrology

Background:

  • Hemodynamic instability in brain death donors (DBD) leads to significant organ loss.
  • Limited evidence exists for managing hemodynamic instability in DBDs, especially marginal donors (older, comorbid).
  • Evolving donor demographics necessitate updated management guidelines.

Purpose of the Study:

  • To summarize evidence on hemodynamic management strategies for DBDs, focusing on vasoactive drugs and monitoring.
  • To review therapeutic approaches for elderly DBDs.
  • To provide guidance for optimizing organ retrieval and transplantation.

Main Methods:

  • Systematic review of available evidence on hemodynamic management in DBDs.
  • Focus on vasoactive drug therapies and monitoring parameters.
  • Inclusion of data on elderly DBD management.

Main Results:

  • Norepinephrine is the primary vasoactive agent globally; vasopressin is recommended for higher doses.
  • Hormonal therapy (desmopressin, corticosteroids, thyroid hormone) is advised for all DBDs.
  • Monitoring, including echocardiography, is key to achieving therapeutic goals.

Conclusions:

  • Optimized donor management is critical for maximizing organ retrieval and transplantation success.
  • Tailored therapeutic regimens, considering organ type, are essential.
  • Adherence to specific monitoring and therapeutic goals improves donor outcomes.